HUKYNDRA |

Alvotech and STADA Pave Way resolve European Patent Dispute With AbbVie and launch UKYNDRA®(AVT02)

April 6, 202212 min read

REYKJAVIK, Iceland & BAD VILBEL, Germany, 06.04.2022 – Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines

Tag: HUKYNDRA

Alvotech and STADA Pave Way resolve European Patent Dispute With AbbVie and launch UKYNDRA®(AVT02)

You May Have Missed

Base Station RF Power Amplifier Market to Experience Significant Growth Amid 5G Expansion and Rising Mobile Device Adoption

World Leaders in Aeronautics, Defence, and Aerospace to Attend the Marrakech Air Show 2024

Sunshine State Dentistry of Boynton Beach Launches New Website to Provide Patients with a Seamless Digital Experience

Metastat Insights Projects Significant Growth in Tattoo Supplies Market by 2031